Skip to Main Content

Paper Details

An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH.
J Hepatol
45
2023
FGF19, FGF21, NASH, PNPLA3, PNPLA3 gene, acetyl-CoA, acetyl-CoA carboxylase, advanced fibrosis, aramchol, auto-aggressive T cells, cirrhosis, fibrosis, galectin-3, hepatic stellate, hepatic stellate cells, hepatocyte, immune cell, innate lymphocyte populations, integrins, lanifibranor, macrophages, matrix, myofibroblasts, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, obeticholic acid, patients, reprogrammed (CAR) T cells, resmetirom, semaglutide
Author NameAffiliation
Frank TackeCharite - Universitatsmedizin Berlin
Rohit LoombaNAFLD Research Center, University of California at San Diego
  • 1 - 2

Datasets

Release 1.2